Famotidine Injection, Solution
Product Images NDC 0338-5197

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 0338-5197). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Famotidine Structural Formula (Image 01)

Chemical structure of famotidine, showing its molecular framework with amino, thiazole, and sulfonamide groups consistent with its identity as the active ingredient.*

FDA Label Image

Famotidine Representative Container Label Ndc 0338-5197-41 (Image 02)

Famotidine Injection 20 mg in a 50 mL single dose container by Baxter Healthcare Corporation. The label includes dosage form as injection solution for intravenous use, with product NDC 0338-5197-41. The container is labeled as iso-osmotic and sterile nonpyrogenic, with cautions and storage instructions printed on the label.*

FDA Label Image

Famotidine Representative Carton Label Ndc 0338-5197-41 (Image 03)

Text panel providing storage recommendations for Famotidine injection solution. It advises storing at room temperature (25°C/77°F), avoiding excessive heat, and states brief exposure up to 35°C/95°F does not adversely affect the product. Also mentions Baxter and GALAXY trademarks of Baxter International Inc. and identifies PL 2501 Plastic.*

FDA Label Image

Famotidine Representative Carton Label Ndc 0338-5197-41 (Image 04)

Famotidine Injection 20 mg in 50 mL single-dose containers by Baxter Healthcare Corporation. The label indicates 12 x 50 mL iso-osmotic solutions for intravenous use, stored at room temperature (25°C/77°F). The label includes NDC 0338-5197-41 and barcode position markings.*

FDA Label Image

Famotidine Representative Carton Label Ndc 0338-5197-41 (Image 05)

Drug facts panel for Famotidine injection solution 20 mg/50 mL from Baxter Healthcare Corporation. The panel lists each 50 mL container contents including famotidine, sodium chloride, and L-aspartic acid. Instructions mention intravenous use as directed by a physician and provide cautions about medication addition, leakage checks, and solution clarity before use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.